LOGO JPG.jpg
Cempra to Report Fourth Quarter and Full Year 2014 Financial Results
February 17, 2015 08:00 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
The National Patient Safety Foundation Logo
National Patient Safety Foundation To Provide Oversight of Research Study on Pneumonia in Hospitalized Patients
February 10, 2015 09:37 ET | The National Patient Safety Foundation
BOSTON, Feb. 10, 2015 (GLOBE NEWSWIRE) -- The National Patient Safety Foundation (NPSF), a central voice for patient safety since 1997, will provide oversight for a research study that is seeking a...
LOGO JPG.jpg
Cempra to Present at Three Upcoming Investor Conferences
February 03, 2015 08:00 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
Cempra Announces Full Exercise of Additional Share Option and Completion of the Public Offering of Common Stock
January 13, 2015 16:01 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Jan. 13, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
Cempra Prices Public Offering of Common Stock
January 07, 2015 20:00 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
Cempra Announces Proposed Public Offering of $100 Million of Common Stock
January 05, 2015 16:02 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Jan. 5, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
Cempra Announces Positive Topline Phase 3 Clinical Results for Oral Solithromycin in the Treatment of Community Acquired Bacterial Pneumonia
January 04, 2015 17:00 ET | Melinta Therapeutics, Inc.
Solithromycin met the primary and secondary objectives of non-inferiority compared to moxifloxacin Cempra to host webcast and conference call on January 5, 2015 at 8:00 a.m. EST CHAPEL HILL,...
LOGO JPG.jpg
Cempra to Participate in Upcoming Investor Events in December
December 03, 2014 16:10 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Dec. 3, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
Cempra to Present at Two Upcoming Investor Conferences
November 10, 2014 16:05 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
Cempra Reports Third Quarter 2014 Financial Results and Provides Corporate Update
October 29, 2014 16:05 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...